A cerebellar mechanism for learning prior distributions of time intervals by Zeeuw, Chris I. De, Narain, Devika, Remington, Evan D, Jazayeri, Mehrdad

Get full text
Get full text
Get full text

Flexible timing by temporal scaling of cortical responses by Wang, Jing, Narain, Devika, Hosseini, Eghbal A., Jazayeri, Mehrdad

Get full text

Frequency Diffeomorphisms for Efficient Image Registration by Zhang, Miaomiao, Liao, Ruizhi, Dalca, Adrian Vasile, Golland, Polina

Get full text

Effects of fluorescent glutamate indicators on neurotransmitter diffusion and uptake by Moritz Armbruster, Chris G Dulla, Jeffrey S Diamond

Get full text

Genetics of Functional Seizures; A Scoping Systematic Review by Ali A. Asadi-Pooya, Mark Hallett, Nafiseh Mirzaei Damabi, Khatereh Fazelian Dehkordi

Get full text

Vascular cognitive impairment (VCI): Progress towards knowledge and treatment by Silvia Di Legge, Vladimir Hachinski

“…For this reason, in 2006 the National Institute of Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) defined a set of data elements to be collected in future studies aimed at defining VCI etiology, clinical manifestations, predictive factors, and treatment. …”
Get full text

A flexible user-interface for audiovisual presentation and interactive control in neurobehavioral experiments [v2; ref status: indexed, http://f1000r.es/15k] by Christopher T Noto, Suleman Mazhar, James Gnadt, Jagmeet S Kanwal

Get full text

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window by Yuanmei Pan, Guowen Shi

“…In 1995, the results of a landmark clinical trial by National Institute of Neurological Disorders and Stroke (NINDS) made a paradigm shift in managing acute cerebral ischemic stroke (AIS) patients at critical care centers. …”
Get full text

Preclinical research in Rett syndrome: setting the foundation for translational success by David M. Katz, Joanne E. Berger-Sweeney, James H. Eubanks, Monica J. Justice, Jeffrey L. Neul, Lucas Pozzo-Miller, Mary E. Blue, Diana Christian, Jacqueline N. Crawley, Maurizio Giustetto, Jacky Guy, C. James Howell, Miriam Kron, Sacha B. Nelson, Rodney C. Samaco, Laura R. Schaevitz, Coryse St. Hillaire-Clarke, Juan L. Young, Huda Y. Zoghbi, Laura A. Mamounas

“…In September of 2011, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the International Rett Syndrome Foundation (IRSF) and the Rett Syndrome Research Trust (RSRT) convened a workshop involving a broad cross-section of basic scientists, clinicians and representatives from the National Institutes of Health (NIH), the US Food and Drug Administration (FDA), the pharmaceutical industry and private foundations to assess the state of the art in animal studies of Rett syndrome (RTT). …”
Get full text

Color Processing in Zebrafish Retina by April Meier, Ralph Nelson, Victoria P. Connaughton

Get full text

The Effectiveness of a Multimodal Brain Empowerment Program in Mild Cognitive Impairment: A Single-Blind, Quasi-Randomized Experimental Study by Wonjun Oh, Haeun Park, Mark Hallett, Joshua (Sung) H. You

Get full text

Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: An unknown danger by Adatia Sweta, Sanghani Sejal, Sanzgiri Prakash, Chauhan Vinay, Hastak Shirish

“…Thrombolysis with intravenous tissue (IV) plasminogen activator (tPA) is considered for patients with acute ischemic stroke falling within the described inclusion criteria defined by The National Institute of Neurological Disorders and Stroke (NINDS) rtPA trial. Complications of IV thrombolysis with tPA are commonly related to hemorrhage, anaphylaxis, or arterial occlusion. …”
Get full text

Low-Dimensional Statistics of Anatomical Variability via Compact Representation of Image Deformations by Zhang, Miaomiao, Wells, William M., Golland, Polina

Get full text

Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease by Stephenson, D, Hu, M, Romero, K, Breen, K, Burn, D, Ben-Shlomo, Y, Bhattaram, A, Isaac, M, Venuto, C, Kubota, K, Little, M, Friend, S, Lovestone, S, Morris, H, Grosset, D, Sutherland, M, Gallacher, J, Williams-Gray, C, Bain, L, Avilés, E, Marek, K, Toga, A, Stark, Y, Forrest Gordon, M, Ford, S

“…Government agencies included EMA, FDA, NINDS/NIH and IMI (Innovative Medicines Initiative). …”

Vasküler Kognitif Bozukluk ve Demans, Alzheimer Demans ve Normal Yaşlanma ile İlişkili Beyin Beyaz Cevher Hiperintensite Değişiklikleri by Ayfer Ertekin

“…The basic clinical criteria of DSM-V and NIA-AA were considered for AD. The DSM-V and NINDS-AIREN diagnostic criteria were used for VCID and probable vascular dementia (VaD). …”
Get full text

A flexible user-interface for audiovisual presentation and interactive control in neurobehavioral experiments [v1; ref status: indexed, http://f1000r.es/wt] by Christopher T Noto, Suleman Mazhar, James Gnadt, Jagmeet S Kanwal

Get full text

Stroke recovery phenotyping through network trajectory approaches and graph neural networks by Sanjukta Krishnagopal, Keith Lohse, Robynne Braun

“…To demonstrate the utility of this approach, we analyzed data from the NINDS tPA trial using the Trajectory Profile Clustering (TPC) method to identify distinct stroke recovery patterns for 11 different neurological domains at 5 discrete time points. …”
Get full text

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke by Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerl, AM

“…Sherita N Chapman,1 Prachi Mehndiratta,1 Michelle C Johansen,1 Timothy L McMurry,2 Karen C Johnston,1,2 Andrew M Southerland1,2 1Department of Neurology, University of Virginia, Charlottesville, VA, USA; 2Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA Abstract: In 1995, the NINDS (National Institute of Neurological Disorders and Stroke) tPA (tissue plasminogen activator) Stroke Study Group published the results of a large multicenter clinical trial demonstrating efficacy of intravenous tPA by revealing a 30% relative risk reduction (absolute risk reduction 11%–15%) compared with placebo at 90 days in the likelihood of having minimal or no disability. …”
Get full text

Distribution of AAV-TK following Intracranial Convection-Enhanced Delivery into Rats by Janet Cunningham, Yoshitsugu Oiwa, Dea Nagy, Greg Podsakoff, Peter Colosi, Krys S. Bankiewicz M.D., Ph.D.

Get full text

A large study reveals no association between APOE and Parkinson's disease by Monica Federoff, Belen Jimenez-Rolando, Michael A. Nalls, Andrew B. Singleton

“…Patients and methods: In total, 3465 case and control samples were genotyped, obtained from the NINDS Neurogenetics repository. Results: No significant differences in ε4 dosages exist between PD cases and controls. …”
Get full text